Two fungal cultures Aspergillus niger and Cunninghamella blakesleeana were used for the biotransformation of methenolone enanthate (1). Biotransformation with A. niger led to the synthesis of three new (2-4), and three known (5-7) metabolites, while fermentation with C. blakesleeana yielded metabolite 6. Substrate 1 and the resulting metabolites were evaluated for their immunomodulatory activities. Substrate 1 was found to be inactive, while metabolites 2 and 3 showed a potent inhibition of ROS generation by whole blood (IC50= 8.60 and 7.05 mu g/mL), as well as from isolated polymorphonuclear leukocytes (PMNs) (IC50= 14.0 and 4.70 mu g/mL), respectively. Moreover, compound 3 (34.21%) moderately inhibited the production of TNF-alpha, whereas 2 (88.63%) showed a potent inhibition of TNF-alpha produced by the THP-1 cells. These activities indicated immunomodulatory potential of compounds 2 and 3. All products were found to be non-toxic to 3T3 mouse fibroblast cells. (C) 2016 Elsevier Inc. All rights reserved.
Verfahren zur Herstellung von 1-Methyl-androsta-1,4-dien-3,17-dion und die neuen Zwischenprodukte für dieses Verfahren
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0290378B1
公开(公告)日:1992-01-02
——
作者:PETZOLDT KARL
DOI:——
日期:——
VERFAHREN ZUR HERSTELLUNG VON 1-METHYL-1,4-ANDROSTADIEN-3,17-DION
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:EP0217840A1
公开(公告)日:1987-04-15
2-IOD-3-KETO-$g(D)?4 -STEROIDE, VERFAHREN ZU IHRER HERSTELLUNG, SOWIE DEREN WEITERVERARBEITUNG